AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots.
AstraZeneca’s review, which covered more than 17 million people vaccinated in the United Kingdom and European Union, comes after health authorities in some countries suspended the use of its vaccine over clotting issues.
“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the company said.
Authorities in Ireland, Denmark, Norway and Iceland have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders.
European Medicines Agency has said there is no indication that the events were caused by the vaccination, a view that was echoed by the World Health Organization on Friday.
The drugmaker said, 15 events of deep vein thrombosis and 22 events of pulmonary embolism have been reported so far, which is similar across other licensed COVID-19 vaccines.
The company said additional testing has and is being conducted by the company and the European health authorities and none of the re-tests have shown cause for concern. The monthly safety report will be made public on the EMA website in the following week, AstraZeneca said.
The AstraZeneca vaccine, developed in collaboration with Oxford University, has been authorized for use in the European Union and many countries but not yet by US regulators.
The company is preparing to file for US emergency use authorization and is expecting data from its US Phase III trial to be available in the coming weeks.
AstraZeneca finds no evidence of increased blood clot risk from COVID-19 vaccine
https://arab.news/m3zk4
AstraZeneca finds no evidence of increased blood clot risk from COVID-19 vaccine
- Health authorities in some countries suspended the use of its vaccine over clotting issues
IAEA board meets over Ukraine nuclear safety concerns
- The war in Ukraine “continues to pose the world’s biggest threat to nuclear safety,” Grossi said
- The mission will assess 10 substations “crucial to nuclear safety,” according to Grossi
VIENNA: The UN nuclear watchdog’s board of governors on Friday discussed nuclear safety in Ukraine, with several countries expressing “growing concern” following Russian attacks on the power grid.
Energy supplies to Ukraine’s nuclear plants have been affected as Russia has pounded its neighbor’s power sector since the start of its 2022 invasion, prompting fears of a nuclear disaster.
The war in Ukraine “continues to pose the world’s biggest threat to nuclear safety,” Rafael Grossi, director general of the International Atomic Energy Agency (IAEA), said when opening the board meeting.
The extraordinary meeting that lasted four hours was called after 13 countries led by the Netherlands expressed in a letter seen by AFP a “growing concern about the severity and urgency of nuclear safety risks” following a series of attacks.
Ukrainian ambassador Yurii Vitrenko told reporters before the meeting that it was “high time” for the IAEA board to discuss the situation.
A weeks-long IAEA expert mission to Ukrainian substations and power plants is under way and expected to wrap up next month, Vitrenko said.
The mission will assess 10 substations “crucial to nuclear safety,” according to Grossi.
Russian Ambassador Mikhail Ulyanov dismissed the board’s gathering as “absolutely politically motivated,” adding there was “no real need to hold such a meeting today.”
Last week, Ukraine’s Chernobyl nuclear power plant temporarily lost all off-site power.
Europe’s biggest nuclear power plant, Zaporizhzhia, occupied by Russian forces since March 2022, has also been repeatedly affected by fighting.
Earlier this month, Russia and Ukraine agreed to a localized ceasefire to allow repairs on the last remaining backup power line supplying Zaporizhzhia.
The line was damaged and disconnected as a result of military activity in early January.
The Zaporizhzhia plant’s six reactors have been shut down since the occupation. But the site still needs electricity to maintain its cooling and security systems.
Moscow and Kyiv have repeatedly accused each other of risking a nuclear catastrophe by attacking the site.
